Flagship Pioneering expands into Asia-Pacific Region, with regional hub in Singapore

Flagship Pioneering, the bioplatform innovation company, today announced its expansion into the Asia-Pacific region, with the opening of a regional hub in Singapore. This follows the company’s expansion into the UK earlier this year. André Andonian has joined Flagship as Chair of Asia Pacific and Senior Advisor to lead Flagship’s presence in the region with a focus on furthering the global reach and impact of Flagship and its companies. He will also serve as an advisor on broader global strategy, regional investor engagement, and institutional development. 

Flagship Pioneering creates and builds platform companies designed to generate multiple products that secure a healthier and more sustainable future. For more than 20 years, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than US$90 billion in aggregate value. The current Flagship ecosystem comprises 43 impactful companies spanning human therapeutics, agriculture, and nutrition.  

The global expansion of Flagship’s presence into the Asia Pacific region follows the opening of the company’s office in London earlier this year. Later this month, Flagship will co-host an event in partnership with the UK Government’s Office for Life Sciences, bringing together top leaders from industry, government, and academia, with a focus on breakthrough innovation.

Afeyan continued, “I am delighted to welcome André to Flagship. André’s deep and longstanding experience working throughout Asia with companies, investors, governments, and other stakeholders will be instrumental in identifying and building meaningful relationships between this vibrant regional ecosystem, Flagship, and our first-in-category platform companies.”